<?xml version="1.0" encoding="UTF-8"?>
<p id="p0030">Feline infectious peritonitis (FIP), caused by the virulent biotype of feline coronavirus (FCoV) of the genus 
 <italic>Alphacoronavirus</italic> in the family 
 <italic>Coronaviridae</italic>, is a progressive and fatal disease of cats. Feline infectious peritonitis virus (FIPV) is a mutated form of the parental enteric form of FCoV, called feline enteric coronavirus (FECV). FIPV infects domestic cats in multiple cat households worldwide (
 <xref rid="bib22" ref-type="bibr">Manasateinkij et al., 2009</xref>; 
 <xref rid="bib32" ref-type="bibr">Pedersen, 2009</xref>, 
 <xref rid="bib30" ref-type="bibr">2014a</xref>). FIP is a serious systemic (pyo-) granulomatous disease that causes protein-rich effusions in the body cavities. This disease progresses severely within a week to few months, before a cat dies (
 <xref rid="bib32" ref-type="bibr">Pedersen, 2009</xref>). Several strategies have been used for supportive treatment against this disease. Anti-inflammatory and immunosuppressive drugs have been used to inhibit the inflammatory process and reduce the clinical signs with an aim to expand the life of a cat. The combination of antivirals and immuno-stimulating drugs has been applied for the treatment of coronaviruses in humans (
 <xref rid="bib31" ref-type="bibr">Pedersen, 2014b</xref>). However, there is no report on the successful use of preventive vaccines and antiviral therapies to treat FIP.
</p>
